NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...
TransMedics has had a tough stretch of late. Last Friday, short-seller Scorpion Capital published a short report on the company. Management vehemently denied wrongdoing, and said it was exploring ...
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and the release of a short-seller report. Data demonstrates that the ...
Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence. TransMedics was the target of an ...
TransMedics' stock has dropped 47% since October 2024 due to missed earnings, reduced revenue guidance, and a critical short report from Scorpion Capital. Despite the valuation drop, high ...
Deep-pocketed investors have adopted a bullish approach towards TransMedics Gr (NASDAQ:TMDX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Headwaters Capital Management highlighted stocks like TransMedics Group, Inc. (NASDAQ:TMDX) in the Q4 2024 investor letter. TransMedics Group, Inc. (NASDAQ:TMDX) is a commercial-stage medical ...
SAN FRANCISCO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report ...